Reported 9 months ago
Kobayashi Pharmaceutical's red yeast rice products led to multiple deaths and hospitalizations, with 5 confirmed deaths, at least 289 hospitalizations, and 1656 seeking medical treatment in Japan. The Ministry of Health, Labour and Welfare in Japan reported an additional 76 suspected deaths related to the consumption of red yeast rice products. The Ministry criticized Kobayashi Pharmaceutical for delayed reporting and announced direct management of death case investigations. Further investigations are ongoing to determine the link between these deaths and the products, with a total of 170 related deaths being examined, of which 76 are currently under investigation.
Source: YAHOO